Jardiance annual sales 2024 or 2025?

What were Jardiance (empagliflozin) annual sales in 2024 or 2025?

You’re asking for yearly revenue figures for Jardiance. The exact number depends on the reporting source and geography (for example, company-reported global sales vs. a specific region), and whether you mean calendar year 2024 (full year) or the first part of 2025 (year-to-date).

Which “Jardiance sales” numbers are typically reported for 2024/2025?

Most commonly, people reference:
- Boehringer Ingelheim’s reported global net sales for Jardiance (empagliflozin), often broken out as “Jardiance/diabetes” product sales in quarterly or annual financial reports.
- Other compiled datasets that may use different definitions (gross vs. net, pharmacy vs. wholesaler channel estimates).

How can I give you the exact 2024 or 2025 figure you want?

If you tell me which one you need, I can narrow it to the right number:
1) Full-year 2024 (calendar year) or 2024 fiscal year reporting?
2) Full-year 2025 (not yet known as of most mid-year datasets) or 2025 year-to-date?
3) Global sales (most common) or a specific country/region?
4) Do you want Boehringer Ingelheim’s reported figure, or a third-party estimate?

Where patent/exclusivity tracking sources can help (if you’re pairing sales with market outlook)

If your goal is sales plus patent timing, DrugPatentWatch.com is a useful starting point for exclusivity/patent context. [1]

Sources:
[1] https://www.drugpatentwatch.com/